Moisés Augusto De Araújo

Dr. Moisés Augusto De Araújo


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MAMoisés Augusto De Araújo
Moisés Augusto De Araújo
OMOsvaldo Malafaia
Osvaldo Malafaia
JFJurandir M. Ribas Filho
Jurandir M. Ribas Filho
LFLivia Fratini
Livia Fratini
Rafael Roesler RoeslerRafael Roesler Roesler
Rafael Roesler Roesler
GIGustavo R. Isolan
Gustavo R. Isolan
Medulloblastoma (MB) is the most common type of malignant pediatric brain tumor. Neuropilin-1 (NRP1), encoded by the NRP1 gene, is a transmembrane glycoprotein overexpressed in several types of cancer. Previous studies indicate that NRP1 inhibition displays antitumor effects in MB models and higher NRP1 levels are associated with poorer prognosis in MB patients. Here, we used a large MB tumor dataset to examine NRP1 gene expression in different molecular subgroups and subtypes of MB. We found overall widespread NRP1 expression across MB samples. Tumors in the sonic hedgehog (SHH) subgroup showed significantly higher NRP1 transcript levels in comparison with Group 3 and Group 4 tumors, with SHH samples belonging to the α, β, Δ, and γ subtypes. When all MB subgroups were combined, lower NRP1 expression was associated with significantly shorter patient overall survival (OS). Further analysis showed that low NRP1 was related to poorer OS, specifically in MB subgroups SHH and Group 3 MB. Our findings indicate that patients with SHH and Group 3 tumors that show lower expression of NRP1 in MB have a worse prognosis, which highlights the need for subgroup-specific investigation of the NRP1 role in MB.

22 August 2025 in Surgical Neurology International
Verified
Journal Article
Open access
ARAlex Roman
Alex Roman
MAMoisés Augusto De Araújo
Moisés Augusto De Araújo
RARudolfh Batista Arend
Rudolfh Batista Arend
BPBruno Zilli Peroni
Bruno Zilli Peroni
DSDaniel Felipe Savaris
Daniel Felipe Savaris
FRFilipe Virgilio Ribeiro
Filipe Virgilio Ribeiro
Background: Olfactory neuroblastoma (ONB) is a rare malignant tumor of the sinonasal cavity, often presenting with nonspecific symptoms and requiring complex multidisciplinary management. Case Description: A 55-year-old male developed progressive anosmia and recurrent epistaxis. Imaging revealed an invasive lesion involving the nasal cavity, paranasal sinuses, and intracranial space, along with cervical lymph node metastases. Diagnosis was confirmed histologically. Patient underwent craniofacial approach, cervical lymphadenectomy, and adjuvant radiotherapy. Despite aggressive treatment, early recurrence occurred in both nasal and intracranial compartments. With curative options exhausted, the patient was transitioned to palliative care. Conclusion: ONB has a high risk of recurrence, typically occurring years after initial treatment. However, early recurrence, as seen in this case, is rare and associated with aggressive tumor features such as high-grade histology and incomplete resection. These cases present significant therapeutic challenges and underscore the importance of close surveillance and further research into optimal management strategies for early recurrent ONB.